Marksans Pharma Limited has formally completed the acquisition of 100% of the share capital of ABCnow GmbH, a company based in Germany. This disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The completion follows an earlier intimation made to the exchanges via a letter dated 8th July 2026. The company has requested that the stock exchanges take this information on record.
The document was signed and submitted by Harshavardhan Panigrahi, Company Secretary of Marksans Pharma Limited, on 20th July 2026 at 16:51:40 IST.